Senate floor wrestles with cannabis testing rules as committee compromise draws sharp objections

Lawmakers spent an extended block of floor time debating how Maine should regulate testing and tracking for medical and adult‑use cannabis products after competing reports from the Veterans and Legal Affairs Committee were presented.

Supporters of the committee compromise (referred to as Report B) argued it was a pragmatic middle ground that preserves the medical program and avoids forcing small caregivers and producers out of business. Senator Timberlake urged colleagues to support the bipartisan compromise, saying it "found the middle ground" and that Report B was the result of hours of committee work aimed at protecting both patients and the industry.

Opponents, including Senator Dusan and Senator Tupler, said medical cannabis should be treated as medicine and subject to rigorous testing. "If it is sold as medicine, it should be tested as such," Senator Dusan said on the floor, citing patient safety and public health. Senator Tupler added, "Patients deserve medicine that's fully tested."

Committee chair Senator Hickman read expert testimony into the record emphasizing the trade‑offs: some experts warned that sweeping new testing mandates could force caregivers and small producers to close, pushing patients toward the illicit market; others urged batch‑testing and stronger oversight to prevent contaminated products reaching medically fragile patients.

During floor action Senator Hickman moved to table the item "until later in today's session," a procedural step that paused immediate finalization of the committee's changes while leadership conferred. The record shows robust disagreement among lawmakers about whether to prioritize strict public‑health testing requirements for medical products or to protect an existing, more flexible medical supply chain.

Next steps: The item remained active on the calendar as senators pursued procedural options; sponsors said they expected further work on testing standards and implementation language before a final vote.